About the Authors
- Shaheen Akhtar
-
Affiliation Medical Research Council Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, London, United Kingdom
- Julia Grizenkova
-
Affiliation Medical Research Council Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, London, United Kingdom
- Adam Wenborn
-
Affiliation Medical Research Council Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, London, United Kingdom
- Holger Hummerich
-
Affiliation Medical Research Council Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, London, United Kingdom
- Mar Fernandez de Marco
-
Affiliation Medical Research Council Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, London, United Kingdom
- Sebastian Brandner
-
Affiliation Medical Research Council Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, London, United Kingdom
- John Collinge
-
Affiliation Medical Research Council Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, London, United Kingdom
- Sarah E. Lloyd
-
* E-mail: s.lloyd@prion.ucl.ac.uk
Affiliation Medical Research Council Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, London, United Kingdom
Competing Interests
JC is a director and shareholder of D-Gen limited, an academic spin-out company in the field of prion diagnosis, decontamination and therapeutics. This does not alter the authors’ adherence to all the PLOS One policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SL. Performed the experiments: SA JG AW MFdeM SL. Analyzed the data: SB HH SL. Wrote the paper: SL JC.